USANA Health Sciences Reports Second Quarter Results

Go back to USANA Health Sciences Reports Second Quarter Results

USANA Health Sciences (USNA) Misses Q2 EPS by 13c; Reiterates Outlook

July 26, 2022 4:07 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.00, $0.13 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $264 million versus the consensus estimate of $268.44 million.

GUIDANCE:

USANA Health Sciences reiterates FY2022 EPS of $3.85-$4.45, versus the... More